Clare Fisher is on the board of Gritstone bio, Inc. and SVP-Business Development, Mergers & Acquisitions at BeiGene Ltd.

In her past career she occupied the position of Chief Business Officer at Kaleido Biosciences, Inc. and Group VP, Head-Transactions & Business Development at Millennium Pharmaceuticals, Inc.

Ms. Fisher received an undergraduate degree from the University of Bath and an MBA from Henley Management College.